WDRB17h
Louisville pharmacy dispensing compounded weight loss drugs in effort to address shortage
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Websites selling compounded weight-loss drugs fail to inform patients of risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
E-sellers of compounded weight-loss drugs fail to reveal risks, research shows
By Bhanvi Satija and Christy Santhosh (Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo ...
pharmaphorum11d
Novo Nordisk asks FDA not to allow GLP-1 compounding
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...
MedPage Today25m
Online Sellers of Compounded GLP-1s Often Don't Mention Risks
Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...
CNBC on MSN24d
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
"If compounded semaglutide goes away as well ... met by our current insurance status" for drugs such as Zepbound. Some ...
NBC Washington24d
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
"If compounded semaglutide goes away as well ... status" for drugs such as Zepbound. Some compounding pharmacies such as Strive Pharmacy are operating as usual pending more updates to the ...